[ad_1] Novavax (NVAX): The earnings per share of the company show a growth of 39.30% for the current year and it is expected that the growth of profits for the next year will reach 11.50%. The analyst predicted ESP growth of 0.00% over the next 5 years. The EPS growth …
Read More »